Peripheral Vascular Disorders
Conference Coverage
Endovascular interventions associated with large benefits in peripheral artery disease
WASHINGTON – Endovascular PAD treatment showed low event rates plus QOL improvements at 18 months, even in Rutherford stage 6 patients.
Conference Coverage
VIDEO: Case for rivaroxaban & aspirin for PAD gets stronger
ORLANDO – Further analysis of PAD patients enrolled in the COMPASS trial strengthens the evidence for benefit from rivaroxaban plus aspirin.
Feature
Thrombectomy’s success treating strokes prompts rethinking of selection criteria
very low number needed to treat for acute ischemic stroke patients to benefit from thrombectomy peaks interest in widening the treatment...
From the Journals
Viremic suppression linked to decreased MACE rate in patients with HCV-cirrhosis
Viremic suppression was associated with a lower rate of cardiovascular events in patients with compensated HCV-related cirrhosis.
Conference Coverage
JAK inhibitors for RA: Is VTE risk overblown?
MAUI, HAWAII – “Certainly we are seeing these events. The question is, ‘How overdone is this?’ ” said Mark C. Genovese, MD.
Video
VIDEO: Stroke benefits from stem cells maintained for 2 years
LOS ANGELES – The acute benefits seen in 13 of 18 chronic stroke patients treated with intracranial cell transplants continued to 2 years’ follow-...
From the Journals
Large-vessel vasculitis: More severe in HIV-infected patients
Large-vessel vasculitis was more severe in HIV-infected individuals.
Conference Coverage
Promising outcomes of thrombolysis for caval extension of iliofemoral DVT
CHICAGO – Acute caval involvement predicts reduced risk of postthrombotic syndrome.
Conference Coverage
On-label stent use looks safe in intracranial atherosclerotic disease
LOS ANGELES – The postmarketing WEAVE study suggests on-label use is key to an acceptable safety profile.
Conference Coverage
Embracing Life’s Simple 7 slashes PAD risk
Optimal adherence to AHA cardiovascular health program reduced PAD risk by 86%.
Conference Coverage
VIDEO: Retinal infarctions get missed as stroke harbingers
LOS ANGELES – Review of more than 5,000 Medicare beneficiaries with retinal infarction showed most don’t receive follow-up stroke assessment.